Reopening America

Moderna Filles for Emergency Use Authorization From the FDA for Its Vaccine Candidate

Moderna has now become the second company to request emergency use authorization from the FDA for their vaccine candidate. In their latest findings, the vaccine is over 94% effective against coronavirus and very effective at preventing serious cases of the virus. The next step will be on Dec. 10 when the FDA will discuss approval for Pfizer and then Dec. 17 for Moderna. Karen Weintraub, health reporter at USA Today, joins us for more as we get closer to vaccine approvals. Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

We have shifted into a new phase in the coronavirus pandemic. We are social distancing, washing our hands, wearing face masks, and we are Reopening America. Oscar Ramirez from the Daily Dive Podcast updates you on any new information about the virus and vaccine development, but will focus on how cities, states, and industries affected by the shutdown are opening back up.